Artificial intelligence (AI) isn't the only industry with explosive growth potential.
Immunology biotech Agomab Therapeutics is seeking to raise up to $212.5 million in its Nasdaq debut, joining a series of ...
DermCeutical EDLTM is a topical bioactive ingredient that Debut claims delivers skin-tightening benefits.
The biotech sector is one that’s become red-hot, at least in recent years. After around a decade of stagnation, investors ...
Explore how leadership in biotech drives success through a milestone approach, aligning teams and culture from science to ...
Delve into what 2026 has to offer in the biotech industry. The market is showing signs it's picking up and the patent cliff ...
The company made an even more dramatic claim the following month, when it announced it had created three dire wolves. These ...
Genentech, a biotechnology company that pledged last year to build a manufacturing facility in southern Wake County, said it ...
A life sciences hub in Syracuse is getting a major upgrade as New York pushes to grow its biotechnology sector. Gov. Kathy ...
Department of Economic & Community Development Commissioner Daniel O'Keefe speaks at the BioCT legislative breakfast in New ...
An inconsistent boom-and-bust cycle funding environment for early-stage biotech innovations and burdensome regulation threaten the U.S.’s half-century-long dominance in the biotech sector.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results